Please login to the form below
6
Revenue 2017Remicade
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Remicade was produced by Johnson & Johnson, Mitsubishi Tanabe Pharma and Merck & Co..
Will biosimilars ever catch on in the US?
Pfizer also cited a Janssen brochure that allegedly implied the biosimilar Inflectra is not interchangeable with Remicade and may pose a safety risk.
J&J earnings top expectations, but feels the squeeze in US
Anti-inflammatory medicine Remicade also saw a sales drop 21% due to price reductions, but its still holding on to a remarkable 93% of its market share, holding out against biosimilar
J&J takes on Novartis’ Cosentyx with head-to-head psoriasis trial
Remicade (infliximab) facing increasing competition from biosimilars. ... TNF inhibitor Remicade’s sales fell by around 15% in the first nine months of the year to $4.1bn, mainly due to price reductions, while Tremfya sales were $369m globally
ViiV’s two-drug HIV combo backed by CHMP
Sandoz’ Zessly, a biosimilar of J&J’s Remicade (infliximab) for the treatment of rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and psoriasis.
Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal
This will be the third biosimilar Mundipharma and Celltrion has launched in the EU, following Remsima (infliximab) and Truxima (rituximab), biosimilars of Johnson and Johnson’s Remicade and Roche’s MabThera.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- AZ strengthens Daiichi Sankyo partnership with new ADC deal
- Novavax reports promising phase 1 results for coronavirus vaccine
- Novartis’ Sandoz division announces antibiotic manufacturing plan
- How will the events and exhibitions industry change post-Coronavirus?
- Merck enters agreement with Hanmi for investigational NASH drug
- Novartis builds its case for novel MS treatment ofatumumab
- Novavax plans to meet US COVID-19 vaccine demand in 2021
- Sinovac begins late-stage COVID-19 vaccine trial
- Seres’ microbiome-based therapy hits the mark in phase 3
- Planning your clinical trial? Why you need to engage patients sooner
- Live Webinar: Re imagining Healthcare through Integrated Digital Health Empowerment
- Combating Coronavirus Through Reversing Diabetes
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
Latest intelligence
- Planning your clinical trial? Why you need to engage patients sooner
- It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
- Patient-centricity in improving patient recruitment advertising
- This blog looks into the importance of concepts and patient centricity in patient recruitment....
- AI: the smart money is on the smart thinking
- Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...
Quick links
Infographics
